Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1936-1943

  Crespo Facorro, Benedicto ^a   Roiz Santiáñez, Roberto ^a   Pérez Iglesias, Rocío ^a   Pelayo Terán, José M ^a   Rodríguez Sánchez, José M ^a   Tordesillas Gutiérrez, Diana ^a   Ramírez, MariLuz ^a   Martínez, Obdulia ^a   Gutiérrez, Agustin ^a   de Lucas, Enrique Marco ^a   Vázquez Barquero, José L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antipsychotic drugs; First episode psychosis; Structural neuroimaging

Indexed keywords

HALOPERIDOL; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HALOPERIDOL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; YOUNG ADULT;

EID: 56449102455     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.09.020     Document Type: Article

References (57)

1. Andersson C., Hamer R.M., Lawler C.P., Mailman R.B., and Lieberman J.A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27 (2002) 143-151
2. Andreasen N.C., Olsen S.A., Dennert J.W., and Smith M.R. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am J Psychiatry 139 (1982) 297-302
3. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) (1983), University of Iowa, Iowa City
4. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) (1984), University of Iowa, Iowa City
5. Andreasen N.C., Flaum M., and Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49 (1992) 615-623
6. Andreasen N.C., Cohen G., Harris G., Cizadlo T., Parkkinen J., Rezai K., et al. Image processing for the study of brain structure and function: problems and programs. J Neuropsychiatry Clin Neurosci (1992) 125-133 Review
7. Andreasen N.C., Rajarethinam R., Cizadlo T., Arndt S., Swayze II V.W., Flashman L.A., et al. Automatic atlas-based volume estimation of human brain regions from MR images. J Compu Assist Tomogr 20 (1996) 98-106
8. Bartzokis G., Lu P.H., Nuechterlein K.H., Gitlin M., Doi C., Edwards N., et al. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res 93 (2007) 13-22
9. Benes F.M., Paskevich P.A., Davidson J., and Domesick V.B. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 329 (1985) 265-273
10. Cohen G., Andreasen N.C., Alliger R., Arndt S., Kuan J., Yuh W.T., et al. Segmentation techniques for the classification of brain tissue using magnetic resonance imaging. Psychiatry Res 45 (1992) 33-51
11. Corson P.W., Nopoulos P., Miller D.D., Arndt S., and Andreasen N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156 (1999) 1200-1204
12. Crespo-Facorro B., Kim J.J., Chemerinski E., Magnotta V., Andreasen N.C., and Nopoulos P. Morphometry of the superior temporal plane in schizophrenia: relationship to clinical correlates. J Neuropsychiatry Clin Neurosci 16 (2004) 284-294
13. Crespo-Facorro B., Perez-Iglesias R., Ramirez-Bonilla M., Martinez-Garcia O., Llorca J., and Vazquez-Barquero J.L. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry 67 (2006) 1511-1521
14. Crespo-Facorro B., Roiz-Santiánez R., Pelayo-Teran J.M., Gonzalez-Blanch C., Perez-Iglesias R., Gutierrez A., et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res 91 (2007) 87-96
15. Crespo-Facorro B., Roiz-Santianez R., Pelayo-Teran J.M., Rodriguez-Sanchez J.M., Perez-Iglesias R., Gonzalez-Blanch C., et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. Neuroimage 35 (2007) 1613-1623
16. Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151 (1994) 1430-1436
17. Chakos M.H., Lieberman J.A., Alvir J., Bilder R., and Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345 (1995) 456-457
18. Chakos M.H., Chakos M.H., Shirakawa O., Lieberman J., Lee H., Bilder R., et al. Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry 44 (1998) 675-684
19. Dazzan P., Morgan K.D., Orr K., Hutchinson G., Chitnis X., Suckling J., et al. Different effects of typical and atypical antipsychotics on gray matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 30 (2005) 765-774
20. DeLisi L.E., Sakuma M., Maurizio A.M., Relja M., and Hoff A.L. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res 130 (2004) 57-70
21. DeLisi L.E., Szulc K.U., Bertisch H.C., Majcher M., and Brown K. Understanding structural brain changes in schizophrenia. Dialogues Clin Neurosci 8 (2006) 71-78
22. Doraiswamy P.M., Tupler L.A., and Krishnan K.R. Neuroleptic treatment and caudate plasticity. Lancet 345 (1995) 734-735
23. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 (2005) 1649-1661
24. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) (2001), New York
25. Frazier J.A., Giedd J.N., Kaysen D., Albus K., Hamburger S., Alaghband-Rad J., et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 153 (1996) 564-566
26. Garver D.L., Holcomb J.A., and Christensen J.D. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol Psychiatry 58 (2005) 62-66
27. Gur R.E., Cowell P., Turetsky B.I., Gallacher F., Cannon T., Bilker W., et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 55 (1998) 145-152
28. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., and Gur R.C. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 155 (1998) 1711-1717
29. Harris G., Andreasen N.C., Cizadlo T., Bailey J.M., Bockholt H.J., Magnotta V.A., et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr 23 (1999) 144-154
30. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., and Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet 344 (1994) 1434
31. Keshavan M.S., Rosenberg D., Sweeney J.A., and Pettegrew J.W. Decreased caudate volume in neuroleptic-naive psychotic patients. Am J Psychiatry 155 (1998) 774-778
32. Konradi C., and Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50 (2001) 729-742
33. Kopelman A., Andreasen N.C., and Nopoulos P. Morphology of the anterior cingulate gyrus in patients with schizophrenia: relationship to typical neuroleptic exposure. Am J Psychiatry 162 (2005) 1872-1878
34. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am J Psychiatry 161 (2004) 1829-1836
35. Lawrie S.M., and Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172 (1998) 110-120
36. Lieberman J., Chakos M., Wu H., Alvir J., Hoffman E., Robinson D., et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 49 (2001) 487-499
37. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 46 (1999) 729-739
38. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 (2005) 1209-1223
39. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62 (2005) 361-370
40. Magnotta V.A., Heckel D., Andreasen N.C., Cizadlo T., Corson P.W., Ehrhardt J.C., et al. Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology 211 (1999) 781-790
41. Magnotta V.A., Harris G., Andreasen N.C., O'Leary D.S., Yuh W.T., and Heckel D. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 26 (2002) 251-264
42. Massana G., Salgado-Pineda P., Junque C., Perez M., Baeza I., Pons A., et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J Clin Psychopharmacol 25 (2005) 111-117
43. McCormick L., Decker L., Nopoulos P., Ho B.C., and Andreasen N. Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophr Res 80 (2005) 73-84
44. Miller D.D., Andreasen N.C., O'Leary D.S., Rezai K., Watkins G.L., Ponto L.L., et al. Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology 17 (1997) 230-240
45. Newton S.S., and Duman R.S. Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 21 (2007) 715-725
46. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
47. Parikh V., Khan M.M., Terry A., and Mahadik S.P. Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats. J Psychiatr Res 38 (2004) 521-529
48. Pillai A., Parikh V., Terry Jr. A.V., and Mahadik S.P. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 41 (2007) 372-386
49. Pressler M., Nopoulos P., Ho B.C., and Andreasen N.C. Insular cortex abnormalities in schizophrenia: relationship to symptoms and typical neuroleptic exposure. Biol Psychiatry 57 (2005) 394-398
50. Scheepers F.E., de Wied C.C., Hulshoff Pol H.E., van de Flier W., van der Linden J.A., and Kahn R.S. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 24 (2001) 47-54
51. Scherk H., and Falkai P. Effects of antipsychotics on brain structure. Curr Opin Psychiatry 19 (2006) 145-150
52. Staal W.G., Hulshoff Pol H.E., Schnack H.G., Hoogendoorn M.L., Jellema K., and Kahn R.S. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry 157 (2000) 416-421
53. Steen R.G., Mull C., McClure R., Hamer R.M., and Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188 (2006) 510-518
54. Tauscher-Wisniewski S., Tauscher J., Logan J., Christensen B.K., Mikulis D.J., and Zipursky R.B. Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study. Schizophr Res 58 (2002) 185-188
55. Toulopoulou T., Grech A., Morris R.G., Schulze K., McDonald C., Chapple B., et al. The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia. Biol Psychiatry 56 (2004) 447-453
56. Weinberger D.R., and McClure R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain. Arch Gen Psychiatry 59 (2002) 553-558
57. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (2003) 663-667